Companies › GRCE

Grace Therapeutics Inc (GRCE)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001444192 · EDGAR filings · Updated 2026-07-28

Grace Therapeutics Inc (GRCE) has reported institutional ownership of 26.2%, with 34 institutional managers holding positions valued at $19.7M per the latest 13F reporting period.

Filings this week (3)

• 2026-07-28 — DEFA14A filed
• 2026-07-28 — Proxy statement (DEF 14A) filed
• 2026-07-28 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-18 — Current report (8-K) filed
• 2026-06-18 — Current report (8-K) filed
• 2026-06-18 — Annual report (10-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Grace Therapeutics Inc has 34 institutional holders and institutional ownership of 26.2%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.

Related companies

BIOTE CORP (BTMD) · Seres Therapeutics Inc (MCRB) · Neonc Technologies HLDGS (NTHI) · PELTHOS THERAPEUTICS INC (PTHS) · Instil Bio Inc (TIL) · AURORA CANNABIS INC NO PAR (ACB)